Peer Review History

Original SubmissionJune 6, 2022
Decision Letter - Marcus Tolentino Silva, Editor

PONE-D-22-16227ALTITUDE AND DEPRESSIVE SYMPTOMS IN THE PERUVIAN POPULATION: ANALYSIS OF A DEMOGRAPHIC AND FAMILY HEALTH SURVEY, 2019PLOS ONE

Dear Dr. Failoc-Rojas,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 Please submit your revised manuscript by Sep 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Marcus Tolentino Silva

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

 "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. 

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Additional Editor Comments:

==============================

ACADEMIC EDITOR: Please consider all reviewers' suggestions.

==============================

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This study evaluated a potential role of high-altitude living (Peruvian population) on the prevalence of depression symptoms (using the Patient Health Questionnaire, PHQ-9). The authors report an association between living above 1500 m and symptoms of depression and suggest that hypobaric hypoxia may represent one mechanism explaining this association.

The authors deal with an interesting and important issue from a scientific and a clinical perspective as well. Although this is a well-designed and nicely presented study, several points should be addressed before a final recommendation can be made:

First, the authors may a bit more in detail discuss (in the intro section) why high-altitude living (and hypobaric hypoxia) may provoke depression. Based on that it should be possible to state a clear hypothesis. You may consider (beside others) the following reviews: PMID: 29517615, PMID: 35661753).

Further, the procedure of recruitment (and inclusion) of study participants may be better explained (possibly including a figure), e.g., total persons eligible, inclusion, exclusion criteria, number of respondents, etc.

Are you sure that potential inter-correlations between predictors with have been sufficiently considered by your statistical approach?

The increase in depressive symptoms is not much different from 1500-2500 m to > 2500 m. If hypoxia would represent a major explaining mechanism, one would expect an increase of symptoms with altitude.

There are several other environmental factors that could influence depression,

e.g., UV-radiation, temperature, etc., but also life-style factors (like diet, physical activity, alcohol consumption, etc.) and employment status. You may elaborate a bit on that.

In my opinion, your data do not support the conclusion that the higher the altitude the more frequent are depressive symptoms. Please, check and explain.

A more clinically useful approach should be provided how to implement your findings.

Please, do not forget to mention other (here not or less considered) risk factors like social support, sleep quality/duration, physical activity….

Reviewer #2: Dear Authors of the research paper entitled "ALTITUDE AND DEPRESSIVE SYMPTOMS IN THE PERUVIAN POPULATION:

ANALYSIS OF A DEMOGRAPHIC AND FAMILY HEALTH SURVEY, 2019" with pleasure, I have read your work that seeks to determine the importance of hypoxia concerning the possible effects that this may have on depression (and mood). Your work is interesting and the sample is essential. Having said that, I have a few observations that require your review in order to consider this work as suitable for publication.

General. The title is very unspecific and could be more "interesting" to the reader, for example, I suggest ideas: Analysis of the differences in the depression score (PHQ-9) at different altitudes in Peru" or something like that.

The STROBE reporting format is incomplete, there is missing information and I suggest to review step by step the available template.

Third, it seems to me that a work like this could benefit from a figure showing the differences (pictorially) between the different elevations.

The justification in relation to elevation due to lower PO2 would seem to be very theoretical, there is evidence to suggest that elevation is associated with such findings, among them:

about PO2 and envirment https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420699/

About suicide at high altitude

https://pubmed.ncbi.nlm.nih.gov/29017474/

About altitude, depression and self-perception

https://pubmed.ncbi.nlm.nih.gov/35020475/

Specific comments

Was the questionnaire conducted in all of Peru? how were the locations classified ? by city altitude ? by canton ? by parishes?

On the other hand, did they use any standard classification about altitude and its ranges? in general there are several classifications (<2,500 m low vs high > 2,500) or the category of low, moderate, high and very high (read this article https://www.frontiersin.org/articles/10.3389/fphys.2021.733928/full )

it is noteworthy that there is less depression above 2500 m and that moderate altitudes have more, so it is essential to categorize the variables on the altitude properly.

In general, the work is interesting, but I think that the observations should be considered to improve the work.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Esteban Ortiz-Prado

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Journal Requirements

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response: We have ensured our manuscript meets the journal’s requirements.

2. Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

Response: We have clarified the sources of funding in the cover letter (“The authors received no specific funding for this work”).

3. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Response: The study has received no funding.

4. If any authors received a salary from any of your funders, please state which authors and which funders.

Response: No author received a salary from any funder.

5. If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Response: The authors received no specific funding for this work.

Response to Reviewers

Reviewer 1

6. The authors may a bit more in detail discuss (in the intro section) why high-altitude living (and hypobaric hypoxia) may provoke depression. Based on that it should be possible to state a clear hypothesis. You may consider (beside others) the following reviews: PMID: 29517615, PMID: 35661753).

Response: Thank you for your feedback. We have better explained the mechanism of hypobaric hypoxia in the development of depression, including the suggested reviews (lines 54-61).

7. The procedure of recruitment (and inclusion) of study participants may be better explained (possibly including a figure), e.g., total persons eligible, inclusion, exclusion criteria, number of respondents, etc. Are you sure that potential inter-correlations between predictors with have been sufficiently considered by your statistical approach?

Response: Thank you. We have better explained the recruitment and inclusion of study participants (lines 85-123 and Figure 1). In addition, we have assessed the Variance Inflation Factor (VIF) and other collinearity diagnostic tests, showing no intercorrelations between predictors (lines 215-217).

8. The increase in depressive symptoms is not much different from 1500-2500 m to > 2500 m. If hypoxia would represent a major explaining mechanism, one would expect an increase of symptoms with altitude.

Response: Thank you. We have better discussed the role of other factors affecting our results (lines 271-284).

9. There are several other environmental factors that could influence depression, e.g., UV-radiation, temperature, etc., but also life-style factors (like diet, physical activity, alcohol consumption, etc.) and employment status. You may elaborate a bit on that.

Response: Thank you. We have discussed the role of other environmental and life-style factors (lines 253-284).

10. In my opinion, your data do not support the conclusion that the higher the altitude the more frequent are depressive symptoms. Please, check and explain.

Response: Thank you. We have revised the conclusion as suggested.

11. A more clinically useful approach should be provided how to implement your findings.

Response: Thank you. We have provided information on how these findings could be implemented in the clinical context (lines 338-343).

12. Please, do not forget to mention other (here not or less considered) risk factors like social support, sleep quality/duration, physical activity…

Response: Thank you. We have mentioned other important risk factors as suggested (lines 253-284).

Reviewer 2

13. The title is very unspecific and could be more "interesting" to the reader, for example, I suggest ideas: Analysis of the differences in the depression score (PHQ-9) at different altitudes in Peru" or something like that.

Response: Thank you for your feedback. We have modified the title as suggested.

14. The STROBE reporting format is incomplete, there is missing information and I suggest reviewing step by step the available template.

Response: Thank you. We have completed the information using the STROBE reporting guideline.

15. Third, it seems to me that a work like this could benefit from a figure showing the differences (pictorially) between the different elevations.

Response: Thank you. We have added a figure (Figure 2) showing the differences in the prevalence of depressive symptoms according to the altitude.

16. The justification in relation to elevation due to lower PO2 would seem to be very theoretical, there is evidence to suggest that elevation is associated with such findings, among them:

About PO2 and environment:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420699/

About suicide at high altitude:

https://pubmed.ncbi.nlm.nih.gov/29017474/

About altitude, depression and self-perception:

https://pubmed.ncbi.nlm.nih.gov/35020475/

Response: Thank you. We have discussed the evidence on altitude and depression (235-284). We have also added the suggested references in the discussion (lines 251-253 and 286-294).

17. Was the questionnaire conducted in all of Peru? How were the locations classified ? By city altitude ? By canton? By parishes?

Response: Thank you. The questionnaire was conducted in all the regions of Peru. We have clarified/added the requested information in lines 85-110.

18. On the other hand, did they use any standard classification about altitude and its ranges? in general there are several classifications (<2,500 m low vs high > 2,500) or the category of low, moderate, high and very high (read this article https://www.frontiersin.org/articles/10.3389/fphys.2021.733928/full)

Response: Thank you. We adapted the standard classification on altitude based on the article of Barry & Pollard, as explained in lines 139-141.

19. It is noteworthy that there is less depression above 2500 m and that moderate altitudes have more, so it is essential to categorize the variables on the altitude properly.

Response: Thank you. We have followed the classification of previous literature for the cutoff value of 2500 m (as explained in Comment #18). In addition, we believe this similarity was subtle and the confidence interval is not so precise to interpret an increasing pattern of depression by altitude. The possible reasons for this finding are explained in lines 257-284.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Marcus Tolentino Silva, Editor

PONE-D-22-16227R1Disparities in the prevalence of screened depression at different altitudes in Peru: A retrospective analysis of the ENDES 2019PLOS ONE

Dear Dr. Failoc-Rojas,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Consider all of Reviewer 2's points. I ask that you take special care to justify the attitude ranges used in population stratification and strictly follow the STROBE guidelines. Please consider writing more about the pathophysiological mechanisms of the findings, as we believe this will be a publication of great interest to our readers. 

==============================

Please submit your revised manuscript by Dec 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Marcus Tolentino Silva

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I appreciate the efforts made by the authors in order to revise their manuscript.

All my points have been considered adequately.

I do not have further comments.

Reviewer #2: Dear authors, thank you for allowing me to review your work entitled "altitude and depressive symptoms in the Peruvian population: analysis of a demographic and family health survey, 2019.

First of all, I would like to congratulate you for bringing to the table such an important issue as the role of the environment, in this case living at high altitudes, on people's health.

Now, once I have reviewed your work, I have many concerns about your manuscript in terms of rigor, that might jeopardize the publication of your work as is, however, I am open to re-consider your work for a future revision if you ammed many of the flaws found within the manuscript.

General comments:

Your paper is not in the correct publication format for this type of study, and you should review the STROBE guidelines and follow each criterion to submit your paper.

Second, their work of revision of the literature is inferior; they have not delved into the subject of the physiopathology of the possible causes behind depression in the inhabitants of high altitudes, nothing is said about the metabolism of serotonin at high altitudes, the role of neurodevelopment is not mentioned, there is no mention of self-perception at high altitude, suicide rates at high altitudes use US data (which has almost no populations living at high altitude) and so on (refeer to the literature for further information https://pubmed.ncbi.nlm.nih.gov/35020475/

Third, the altitude ranges are arbitrary; why do they use that range? Where do they get it from? The altitude ranges have been described previously and are well known among those who do high altitude medicine, they can use the simple range of low and high altitude (< or > 2,500 m) or the range of low (<1500), moderate (1500-2500), high altitude (2500-3500) and very high altitude (3,500 to 4300 m) see the following work for further detail https://pubmed.ncbi.nlm.nih.gov/34675818/

If you cannot analyze the results with those altitude ranges, it is difficult for me to accept it for publication unless you have a substantiated and factual response. Now the statistical analysis is adequate, even though it excludes essential factors such as the length of residence of the highlanders, they were born at high altitudes or they only live at higher altitudes. What about the discussion around culture, why not comparing indigenous people of low altitudes with those indigenouse people at high altitudes, i.e., you can analyze proportions between low versus high, but among the same ethnic group, are there differences?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Martin Burtscher

Reviewer #2: Yes: Esteban Ortiz-Prado

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Response to reviewer 2

1. Your paper is not in the correct publication format for this type of study, and you should review the STROBE guidelines and follow each criterion to submit your paper.

Response: Thank you. We have followed the STROBE guideline as suggested. We welcome any additional details that may be necessary.

2. Second, their work of revision of the literature is inferior; they have not delved into the subject of the physiopathology of the possible causes behind depression in the inhabitants of high altitudes, nothing is said about the metabolism of serotonin at high altitudes, the role of neurodevelopment is not mentioned, there is no mention of self-perception at high altitude, suicide rates at high altitudes use US data (which has almost no populations living at high altitude) and so on (refer to the literature for further information https://pubmed.ncbi.nlm.nih.gov/35020475/

Response: Thank you. This information was stated in line 54. However, we have added more detail in lines 71 and 76.

3. Third, the altitude ranges are arbitrary; why do they use that range? Where do they get it from? The altitude ranges have been described previously and are well known among those who do high altitude medicine, they can use the simple range of low and high altitude (< or > 2,500 m) or the range of low (<1500), moderate (1500-2500), high altitude (2500-3500) and very high altitude (3,500 to 4300 m) see the following work for further detail https://pubmed.ncbi.nlm.nih.gov/34675818/

Response: Thank you for your feedback. We understand your point, but we disagree that the altitude ranges used in the study are arbitrary, as it follows standard classifications (shown in cite 14). Additionally, they were considered in a previous Peruvian report (cite 15) and other articles used similar categorizations (see https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330906/ and https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647184/). Therefore, we feel it is of value for the literature. Despite this, we have considered the suggested cut-off points and presented two additional analyses with both simple and extended altitude ranges (Please see Line 149, Line 230, and Supplementary Tables 1 and 2).

4. What about the discussion around culture, why not comparing indigenous people of low altitudes with those indigenous people at high altitudes, i.e., you can analyze proportions between low versus high, but among the same ethnic group, are there differences?

Response: Thank you. We appreciate your comment and contribution to our study. We have analyzed the proportions of the outcome according to the ethnic groups. Please see line 232 and Supplementary Table 4.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Marcus Tolentino Silva, Editor

Disparities in the prevalence of screened depression at different altitudes in Peru: A retrospective analysis of the ENDES 2019

PONE-D-22-16227R2

Dear Dr. Failoc-Rojas,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Marcus Tolentino Silva

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you.

The authors have already addressed adequately all my comments in revision 1.

I do not have further comments.

Reviewer #2: Dear Authors, the work is much better in this version. The changes are positive. I am still not convinced about the height ranges, and although other people have used them, that does not mean that they are the most recognized, in short, the additional analysis contributes to improving the quality of the work. For the rest, I think the work is fine, I would improve the forest plot somewhat; although the title is good in the graph, it does not sound good, maybe explain it in the title of the figure. For the rest, I have no more comments

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Martin Burtscher

Reviewer #2: Yes: Esteban Ortiz-Prado

**********

Formally Accepted
Acceptance Letter - Marcus Tolentino Silva, Editor

PONE-D-22-16227R2

Disparities in the prevalence of screened depression at different altitudes in Peru: A retrospective analysis of the ENDES 2019

Dear Dr. Failoc-Rojas:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Marcus Tolentino Silva

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .